 WATERTOWN, Mass.--BUSINESS WIRE--SQZ Biotechnologies NYSE: SQZ, focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be presenting at Citis 16th Annual Virtual Biopharma Conference on September 10, and at the H. C. Wainwright 23rd Annual Global Investment Conference on September 13. Armon Sharei, Ph.D., Chief Executive Officer, will present a corporate overview and the company will be hosting one-on-one meetings at b 